• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Beyond the buzzword: Patient centricity takes hold

Beyond the buzzword: Patient centricity takes hold

July 1, 2016
CenterWatch Staff

Patient centricity has become a bit of an industry darling—the buzzword is everywhere. Thousands of articles, images and conference talks have been devoted to raising the patient-centric bar in an effort to elevate patient perspective and find better ways to incorporate the needs of patients and caregivers—all as a path to improved clinical research.

Conceptually, we understand that clinical research has the most to gain when patients are not simply respect­ed participants, but viewed as valued partners with all study and clinical research stakeholders, at every step along the way.

If patient centricity is a criti­cal component of any study’s suc­cess, how do we collectively move the needle in the months and years ahead? What key strategies and tac­tics are needed to ensure that pa­tients are equal partners? I believe the real work begins with new and renewed commitments to improve multi-stakeholder collaboration and patient data transparency.

The 21st Century Cures Act is ex­pected to pass later this year. While much has been discussed about the act’s aim to reform significant as­pects of the FDA to help “modernize clinical trials” and support efficien­cies that will lead to faster cures, less has been written about its promise to “put patients first.” The life sciences industry will always be grounded by regulatory requirements, but the 21st Century Cures Act gives us a glimpse of what could and should be: regulation is catching up—and not a hindrance to—science.

Not everyone loves the phrase “we are all patients,” but the idea that we are all working together from a place of real care and empathy, is an im­portant one. Treating and viewing all patients as equal partners is not only the right thing to do, it’s benefi­cial to the study overall.

We all know the stats. Bringing a drug to market costs hundreds of millions of dollars or more, and only one of every 5,000 to 10,000 com­pounds investigated becomes an approved drug. Bettering that ratio, even marginally, could make a huge difference in the lives of patients and their families. We know we can do better. The need to enhance research across all areas is urgent, and patient-centric strategies can help.

 

Written by Guest Writer Bonnie A. Brescia. Brescia is a founding principal of BBK Worldwide, the world leader in patient recruitment for clinical research and development. A pioneer of patient recruitment over the last 30 years, Bonnie helped to shape the discipline and continues to be a well-recognized and highly sought after thought leader in the field. Her insights regarding the global clinical research community inform the industry and help fuel BBK’s leadership, innovation and global expansion. www.bbkworldwide.com

This article was reprinted from Volume 23, Issue 07, of The CenterWatch Monthly, an industry leading publication providing hard-hitting, authoritative business and financial coverage of the clinical research space. The Action Items section features short columns  focusing on actionable or how-to advice from clinical trial professionals. To submit an Action Item, please contact editorial@centerwatch.com. Subscribe >>

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing